Current and historical daily PE Ratio for Thor Medical ASA (
) from 2015 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Thor Medical ASA stock (LTS:0R6Y) PE ratio as of May 28 2024 is 9999.
More Details
Thor Medical ASA (LTS:0R6Y) PE Ratio (TTM) Chart
Thor Medical ASA (LTS:0R6Y) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1277
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Thor Medical ASA PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-28 | At Loss | 2024-03-21 | At Loss |
| 2024-05-24 | At Loss | 2024-03-20 | At Loss |
| 2024-05-23 | At Loss | 2024-03-19 | At Loss |
| 2024-05-22 | At Loss | 2024-03-18 | At Loss |
| 2024-05-21 | At Loss | 2024-03-15 | At Loss |
| 2024-05-20 | At Loss | 2024-03-14 | At Loss |
| 2024-05-17 | At Loss | 2024-03-13 | At Loss |
| 2024-05-16 | At Loss | 2024-03-12 | At Loss |
| 2024-05-15 | At Loss | 2024-03-11 | At Loss |
| 2024-05-14 | At Loss | 2024-03-08 | At Loss |
| 2024-05-13 | At Loss | 2024-03-07 | At Loss |
| 2024-05-10 | At Loss | 2024-03-06 | At Loss |
| 2024-05-09 | At Loss | 2024-03-05 | At Loss |
| 2024-05-08 | At Loss | 2024-03-04 | At Loss |
| 2024-05-07 | At Loss | 2024-03-01 | At Loss |
| 2024-05-03 | At Loss | 2024-02-29 | At Loss |
| 2024-05-02 | At Loss | 2024-02-28 | At Loss |
| 2024-05-01 | At Loss | 2024-02-27 | At Loss |
| 2024-04-30 | At Loss | 2024-02-26 | At Loss |
| 2024-04-29 | At Loss | 2024-02-23 | At Loss |
| 2024-04-26 | At Loss | 2024-02-22 | At Loss |
| 2024-04-25 | At Loss | 2024-02-21 | At Loss |
| 2024-04-24 | At Loss | 2024-02-20 | At Loss |
| 2024-04-23 | At Loss | 2024-02-19 | At Loss |
| 2024-04-22 | At Loss | 2024-02-16 | At Loss |
| 2024-04-19 | At Loss | 2024-02-15 | At Loss |
| 2024-04-18 | At Loss | 2024-02-14 | At Loss |
| 2024-04-17 | At Loss | 2024-02-13 | At Loss |
| 2024-04-16 | At Loss | 2024-02-12 | At Loss |
| 2024-04-15 | At Loss | 2024-02-09 | At Loss |
| 2024-04-12 | At Loss | 2024-02-08 | At Loss |
| 2024-04-11 | At Loss | 2024-02-07 | At Loss |
| 2024-04-10 | At Loss | 2024-02-06 | At Loss |
| 2024-04-09 | At Loss | 2024-02-05 | At Loss |
| 2024-04-08 | At Loss | 2024-02-02 | At Loss |
| 2024-04-05 | At Loss | 2024-02-01 | At Loss |
| 2024-04-04 | At Loss | 2024-01-31 | At Loss |
| 2024-04-03 | At Loss | 2024-01-30 | At Loss |
| 2024-04-02 | At Loss | 2024-01-29 | At Loss |
| 2024-03-29 | At Loss | 2024-01-26 | At Loss |
| 2024-03-28 | At Loss | 2024-01-25 | At Loss |
| 2024-03-27 | At Loss | 2024-01-24 | At Loss |
| 2024-03-26 | At Loss | 2024-01-23 | At Loss |
| 2024-03-25 | At Loss | 2024-01-22 | At Loss |
| 2024-03-22 | At Loss | 2024-01-19 | At Loss |
Thor Medical ASA (LTS:0R6Y) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Thor Medical ASA
ISIN : NO0010597883
Compare
Compare
Traded in other countries / regions
TRMED.Norway8NN.Germany0R6Y.UKNANOo.SwedenNRNVF.USA IPO Date
2015-04-29Description
Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers